| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |